Head of Investor Relations
Ionis Pharmaceuticals Inc (IONS)Equibles does not estimate personal net worth.
Get an email with a short summary when Ionis Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get IONS alertsWade Walke is recorded as Head of Investor Relations at Ionis Pharmaceuticals Inc (IONS). Wade Walke has spoken on 18 earnings calls across 1 company, most recently for Ionis Pharmaceuticals Inc on July 29, 2026. Ionis Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ionis Pharmaceuticals Inc includes Brett Monia (CEO), Elizabeth Hougen (CFO), Patrick R. O’Neil (General Counsel) and 5 others.
“Before we begin, I encourage everyone to go to the Investor section of the IONIS website to view the press release and related financial tables we will be discussing today, including a reconciliation of GAAP to non-GAAP financials.”
“Before we begin, I encourage everyone to go to the Investors section of the Ionis website to view the press release and related financial tables we will be discussing today, including a reconciliation of GAAP to non-GAAP financials.”
“Before we begin, I encourage everyone to go to the Investors section of the IONIS website to view the press release and related financial tables we will be discussing today, today, including a reconciliation of GAAP to non-GAAP financials.”
“Before we begin, I encourage everyone to go to the Investors section of the Ionis Pharmaceuticals, Inc. website to view the press release and related financial tables we will be discussing today, including a reconciliation of GAAP to non-GAAP financials.”
“Before we begin, I encourage everyone to go to the Investors section of the Ionis website to view the press release and related financial tables that we will be discussing today, including a reconciliation of our GAAP to non-GAAP financials.”
Biotechnology · Healthcare
Head of Investor Relations
